NEW YORK, July 26 - Dutch pharmaceutical company Organon had agreed to renew and expand its subscription to Lexicon’s OmniBank library and DNA sequence database, Lexicon Genetics said Thursday.

Under the terms of the deal, Oragnon will have access to Lexicon’s tools through December 2002. In addition, Organon will also have access to Lexicon’s gene knockouts as well as to drug target validation data generated by Lexicon for specified targets.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

Robert Redfield is floated as the next director of the US Centers for Disease Control and Prevention, the Washington Post reports.

The New York Times writes that the National Institutes of Health's All of Us Research Program is "ambitious" and that some are concerned it might be overly so.

Representative Lamar Smith's criticism of the National Science Foundation has "changed the nature of the conversation," according to ScienceInsider.

In PLOS this week: non-coding RNA function in yeast, transcriptomic profiles of malaria parasites, and more.